How should clinicians assess craving and relapse risk in practice?

How should clinicians assess craving and relapse risk in practice?

• A. Rely solely on patient self-report without structured scales
• B. Use validated craving scales and regular check-ins
• C. Ignore triggers and focus on abstinence
• D. Wait until relapse occurs before assessing risk

Answer: (B)

Regularly assessing craving and relapse risk relies on using validated craving scales and scheduling regular check-ins. Craving varies with stress, withdrawal, and cues, and validated scales provide a standardized, reliable way to quantify intensity, frequency, and triggers over time. Ongoing check-ins let clinicians track trends, detect early warning signs, and adapt treatment to strengthen coping skills, adjust supports, or modify medications before a lapse occurs. Relying solely on unstructured self-report, ignoring triggers, or waiting for relapse to happen reduces timing and quality of intervention, increasing the risk of missed opportunities to prevent relapse.

Regularly assessing craving and relapse risk relies on using validated craving scales and scheduling regular check-ins. Craving varies with stress, withdrawal, and cues, and validated scales provide a standardized, reliable way to quantify intensity, frequency, and triggers over time. Ongoing check-ins let clinicians track trends, detect early warning signs, and adapt treatment to strengthen coping skills, adjust supports, or modify medications before a lapse occurs. Relying solely on unstructured self-report, ignoring triggers, or waiting for relapse to happen reduces timing and quality of intervention, increasing the risk of missed opportunities to prevent relapse.